← Back to Search

EHR-Based Intervention B for Critical Illness (PONDER-ICU Trial)

N/A
Waitlist Available
Led By Scott D Halpern, PhD, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48-72 hours following an in-hospital death
Awards & highlights

PONDER-ICU Trial Summary

This trial is testing whether two different electronic health record interventions can improve patient care and outcomes without raising costs.

PONDER-ICU Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48-72 hours following an in-hospital death
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48-72 hours following an in-hospital death for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite Measure: Length of Stay and In-Hospital Mortality
Secondary outcome measures
180-day hospital readmission
180-day mortality
30-day hospital readmission
+17 more

PONDER-ICU Trial Design

4Treatment groups
Active Control
Group I: EHR-Based Intervention BActive Control1 Intervention
Intervention B (Accountable Justification) will be an EHR-based screen prompt triggered for eligible patients. The intervention will consist of no more than two questions that can be completed in two minutes or less. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
Group II: Pre-Intervention (Control)Active Control1 Intervention
There is no trial-driven approach to care. All hospitals contribute a minimum of 5 months of outcomes data prior to adopting the intervention. Pre-specified outcomes data will be electronically extracted for patients meeting eligibility criteria but there will be no attempt to influence delivery of usual care within the hospital. The length of the control phase will differ at each hospital, dependent on the sequence in which hospitals are assigned to switch to the intervention phase.
Group III: Combined EHR-Based Intervention (A+B)Active Control2 Interventions
Intervention A and B prompts will be combined and triggered for eligible patients simultaneously. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
Group IV: EHR-Based Intervention AActive Control1 Intervention
Intervention A (Prognostication) will be an EHR-based screen prompt triggered for eligible patients. The intervention will consist of no more than two questions that can be completed in two minutes or less. Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.

Find a Location

Who is running the clinical trial?

Donaghue Medical Research FoundationOTHER
23 Previous Clinical Trials
574,967 Total Patients Enrolled
1 Trials studying Critical Illness
2,500 Patients Enrolled for Critical Illness
Wake Forest University Health SciencesOTHER
1,239 Previous Clinical Trials
1,000,683 Total Patients Enrolled
10 Trials studying Critical Illness
1,015 Patients Enrolled for Critical Illness
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,876,588 Total Patients Enrolled
9 Trials studying Critical Illness
12,576 Patients Enrolled for Critical Illness

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~488 spots leftby Apr 2025